NEW MJ NEWS

Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023, at 8:00 a.m. EDT in Boston, MA.

A webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company’s KORSUVA® (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. The Company is developing an oral formulation of difelikefalin and has Phase 3 programs ongoing for the treatment of pruritus in patients with advanced chronic kidney disease and atopic dermatitis. In addition, the Company has initiated a Phase 2/3 program of oral difelikefalin for the treatment of moderate-to-severe pruritus in patients with notalgia paresthetica. For more information, visit www.CaraTherapeutics.com and follow the company on Twitter, LinkedIn and Instagram.

MEDIA CONTACT:
Annie Spinetta
6 Degrees
973-768-2170
aspinetta@6degreespr.com

INVESTOR CONTACT:
Iris Francesconi, Ph.D.
Cara Therapeutics
203-406-3700
investor@caratherapeutics.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Sundial Growers (SNDL) to Announce Third Quarter 2020 Financial Results on November 11, 2020

Sundial Growers to Announce Third Quarter 2020 Financial Results on November 11,…

AYR Wellness Inc. (AYRWF) Launches Adult-Use Sales in Ohio

AYR Wellness Launches Adult-Use Sales in Ohio AYR Wellness Inc. (CSE: AYR.A,…

$VPCO Provides Update on Retail Store

Vapor Corp. Provides Update on Retail Store Expansion Program and Acquisition Strategy…

Nabis Holdings (OTC: NABIF) (CSE: NAB) Announces Upsize of Previously Announced Debenture Unit Private Placement Offering to C$35 Million

VANCOUVER, British Columbia, March 07, 2019 (GLOBE NEWSWIRE) — Nabis Holdings (CSE:NAB;…